Labshake search
Citations for Lonza :
1 - 50 of 449 citations for Poloxamer 188 solution since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... solution DMEM (Lonza) solution ...
-
bioRxiv - Cancer Biology 2021Quote: ... in Solution V (Lonza), using program A-023 on an Amaxa nucleofector ...
-
Antigen Geometry Tunes Mast Cell Signaling Through Distinct FcεRI Aggregation and Structural ChangesbioRxiv - Biophysics 2023Quote: ... with Solution L (Lonza VCA-1005 or MirusBio Ingenio solution MIR-50114 ...
-
bioRxiv - Cell Biology 2023Quote: ... using SF solution (Lonza) following the manufacturer’s instructions ...
-
bioRxiv - Genetics 2020Quote: ... with Amaxa solution SF (Lonza) and program CA-150 ...
-
bioRxiv - Cell Biology 2021Quote: ... 1.0% 100× glutamine solution (Lonza), and 1.0% 100× penicillin/streptomycin antibiotic solution (Lonza) ...
-
bioRxiv - Cell Biology 2021Quote: ... 1.0% 100× glutamine solution (Lonza), and 1.0% 100× penicillin/streptomycin antibiotic solution (Lonza) ...
-
bioRxiv - Genomics 2024Quote: ... Gel Slick Solution (Lonza, 50640); Formamide ...
-
Nonsense Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells with SF3B1 and U2AF1 MutationsbioRxiv - Cell Biology 2021Quote: ... using solution P3 (Lonza, #V4XP-3024), program FF-120 in small cuvettes according to the manufacturer’s recommended protocol ...
-
bioRxiv - Cancer Biology 2024Quote: ... with solution T (VCA-1002, Lonza), program A-23 ...
-
bioRxiv - Cell Biology 2020Quote: ... Approximately 200,000 cells were resuspended in a mixture of room temperature Amaxa solution (16.4 μl SF Solution, 3.6 μl Supplement (Lonza)) ...
-
bioRxiv - Immunology 2020Quote: ... resuspended in 20 μL solution SF (Lonza) and combined with 10 μM gRNA together with 0.5 μM GUIDE-seq dsDNA donor fragment ...
-
bioRxiv - Cancer Biology 2020Quote: ... neutralized with trypsin neutralizing solution (Lonza, Germany) and stained with DAPI (Roche Diagnostics ...
-
bioRxiv - Microbiology 2020Quote: ... resuspended in 100μl SF Nucleofector solution (Lonza), mixed with 250ng replicon RNA per 80k cells ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were resuspended in electroporation solution (Lonza) along with 1ug pORANGE plasmid DNA construct ...
-
bioRxiv - Immunology 2022Quote: ... then re-suspended in P3 solution (Lonza), prostaglandin E2 (PGE2) ...
-
bioRxiv - Genomics 2020Quote: ... 1% non-essential amino acid solution (Lonza), and 1% antibiotic-antimycotic solution (Thermo Fisher Scientific ...
-
bioRxiv - Microbiology 2021Quote: ... with 100 μl of P3 solution (Lonza) containing 30 μg of plasmid ...
-
bioRxiv - Cancer Biology 2021Quote: ... and SG Cell Line Nucleofector Solution (Lonza) were mixed in 1.87 uL ...
-
bioRxiv - Immunology 2020Quote: ... 1% Non-Essential Amino Acid Solution (Lonza), 1% Sodium Pyruvate (Gibco) ...
-
bioRxiv - Genomics 2023Quote: ... or P3 primary cell nucleofection solution (Lonza) (iPSC-iCas9) ...
-
bioRxiv - Molecular Biology 2024Quote: ... or nucleofected with solution F (Lonza Inc) according to manufacturer’s recommendations ...
-
bioRxiv - Microbiology 2024Quote: ... 1% HEPES buffered solution (Lonza CC-5022), 1% sodium pyruvate (Gibco 11360-070) ...
-
bioRxiv - Neuroscience 2021Quote: ... cells were washed with room temperature Hank’s Balanced Salt Solution (HBSS) and incubated at 37°C with Versene (EDTA) solution (Lonza) for 3-5 minutes ...
-
bioRxiv - Cell Biology 2022Quote: ... 90 μL of nucleofection solution (16.2 μL of Supplement solution mixed with 73.8 μL of SF solution from SF Cell Line 4D-Nucleofector™ X Kit L) (Lonza) was mixed thoroughly with the cell pellet ...
-
bioRxiv - Immunology 2020Quote: ... Cell pellets were resuspended in 17 μL of P3 transfection solution (13.94 μL of Nucleofector Solution with 3.06 μL of supplement, Lonza, Walkersville, MD) and 4 μL of RNP complexes were added for each reaction ...
-
bioRxiv - Molecular Biology 2022Quote: ... cells were resuspended in 90 µL of nucleofection solution (16.2 µL of Supplement solution mixed with 73.8 µL of SF solution from SF Cell Line 4D-Nucleofector™ X Kit L) (Lonza), transferred to the 15 µL RNP solution ...
-
bioRxiv - Cancer Biology 2022Quote: ... and resuspended in a mixture of 16.4 µl SF cell line solution and 3.6 µl supplemental solution-1 (Lonza, V4XC-2032). The sgRNA and Cas9 ribonuclease protein complex under incubation was then mixed with the cell suspension and 20 µl of it was put a cuvette and nucleofected using 4D-Nucleofector (Lonza ...
-
bioRxiv - Bioengineering 2022Quote: ... 90 μL of nucleofection solution (16.2 μL of Supplement solution mixed with 73.8 μL of SF solution from SF Cell Line 4D-Nucleofector™ X Kit L) (Lonza) was mixed thoroughly with the cell pellet ...
-
bioRxiv - Molecular Biology 2022Quote: ... 1 µg of digested plasmid was added to the bottom of a 1.5 mL tube and 800,000 cells suspended in 20 µL SE nucleofection solution (16.4 µL nucleofection solution, 3.6 µL nucleofection supplement, Lonza, V4XC-1012). The solution was then transferred to a well in a 16-well Nucleocuvette™ Strip and nucleofected in a Lonza 4D-Nucleofector™ running the CM-104 program for U-2 OS cells ...
-
bioRxiv - Immunology 2024Quote: ... 1-2*106 T-ALL cells were resuspended in 100uL P3 nucleofector solution (82 uL nucleofection solution + 18 uL supplement; Lonza P3 Primary Cell 4D-NucleofectorTM X Kit) ...
-
bioRxiv - Molecular Biology 2024Quote: ... Cell passaging was performed with 0.05% (w/v) trypsin solution (#204-16935, FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) and trypsin neutralizing solution (CC-5002, Lonza). To pellet the cells during the cell passaging ...
-
bioRxiv - Molecular Biology 2022Quote: ... or P3 Primary Cell Solution (V4XP-3032, Lonza), respectively ...
-
bioRxiv - Genomics 2020Quote: ... and 1% non-essential amino acid solution (Lonza) at 37°C in a humidified atmosphere containing 5% CO2 ...
-
bioRxiv - Microbiology 2021Quote: ... 100 U/ml penicillin-streptomycin antibiotic solution (Lonza) and 2 mM UltraGlutamine (alanyl L-glutamine ...
-
bioRxiv - Cell Biology 2021Quote: ... was resuspended in 100 µl Nucleofector solution (Lonza) containing ∼5 µg of desired circular (pSTCII-GFP/PfAtg18 ...
-
bioRxiv - Neuroscience 2020Quote: ... Nucleofection Solution for human stem cells II (Lonza), and program B-16 ...
-
bioRxiv - Genetics 2022Quote: ... and resuspended in P3 4D nucleofector solution (Lonza) including RNP complex and electroporation enhancer (IDT) ...
-
bioRxiv - Neuroscience 2022Quote: ... solution applied to a Gel Slick (Lonza 50640) treated 2×3 glass slide ...
-
bioRxiv - Neuroscience 2022Quote: ... solution applied to a Gel Slick (Lonza 50640) treated 2×3 glass slide ...
-
bioRxiv - Biochemistry 2021Quote: ... Cells were resuspended in Nucleofector solution from Lonza. SF cell line 4d-Nucleofector X kit S (V4XC-2032 ...
-
bioRxiv - Cell Biology 2021Quote: ... and 1.0% 100× penicillin/streptomycin antibiotic solution (Lonza). Cells were maintained at 37 °C in a humidified ...
-
bioRxiv - Cell Biology 2021Quote: ... and 1.0% 100× penicillin/streptomycin antibiotic solution (Lonza). 72 h post-transfection ...
-
bioRxiv - Neuroscience 2022Quote: ... solution applied to a Gel Slick (Lonza 50640) treated 2×3 glass slide ...
-
bioRxiv - Cancer Biology 2024Quote: ... 0.1 mM non-essential amino acid solution (Lonza), and 1 mM sodium pyruvate (Lonza).
-
bioRxiv - Cell Biology 2023Quote: — Trypsin Neutralizing Solution (Lonza cat. no. CC-5002)
-
bioRxiv - Cell Biology 2023Quote: — Trypsin/EDTA Solution (Lonza cat. no. CC-5012)
-
bioRxiv - Immunology 2024Quote: ... neutralized with Trypsin Neutralizing Solution (CC-5002; Lonza), pelleted (200g ...
-
bioRxiv - Cell Biology 2024Quote: ... resuspended in 91 µl supplemented Solution T (Lonza) and mixed with 2.5 µl of each pre-assembled RNP and 4 µl electroporation enhancer (Integrated DNA technologies) ...
-
bioRxiv - Immunology 2024Quote: ... using the P3 Primary Cell Nucleofector Solution (Lonza), 120 bp ssDNA non-targeting electroporation stabilizer (IDT) ...